TrialMolecular therapy : the journal of the American Society of Gene Therapy2011

A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma.

Tae-Ho Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.